Cheryl E. Balkman
Cornell University
32 Papers
96 Citations
Cheryl E. Balkman is an academic researcher from Cornell University. The author has contributed to research in topics: Medicine & Chemotherapy. The author has an hindex of 14, co-authored 31 publications.
Chat about Author
Papers
Complex disease and phenotype mapping in the domestic dog.
Jessica J. Hayward,Marta Castelhano,Kyle C. Oliveira,Elizabeth Corey,Cheryl E. Balkman,Tara L. Baxter,Margret L. Casal,Meiying Fang,Susan J. Garrison,Sara E. Kalla,Pavel Korniliev,Michael I. Kotlikoff,N. S. Moise,Laura M. Shannon,Kenneth W. Simpson,Nathan B. Sutter,Rory J. Todhunter,Adam R. Boyko +17 more
TL;DR: The largest canine genome-wide association study to date, with a panel of over 4,200 dogs genotyped at 180,000 markers, is undertaken, to accelerate mapping efforts of canine complex diseases.
Combination of CCNU and DTIC chemotherapy for treatment of resistant lymphoma in dogs.
Andrea B. Flory,Kenneth M. Rassnick,R. Al-Sarraf,D. B. Bailey,Cheryl E. Balkman,M. A. Kiselow,Karoliina Autio +6 more
TL;DR: A combination of CCNU and DTIC that is well tolerated can be used to treat dogs with lymphoma that developed resistance or failed to respond to previously administered chemotherapy.
60
Comparison of 3 Protocols for Treatment after Induction of Remission in Dogs with Lymphoma
Kenneth M. Rassnick,Margaret C. McEntee,Hollis N. Erb,Blaise P. Burke,Cheryl E. Balkman,Andrea B. Flory,M. A. Kiselow,Karoliina Autio,Tracy L. Gieger +8 more
TL;DR: Consolidation with either CCNU/MOPP or HBRT showed no advantage over a standard CHOP-based protocol and overall remission duration and survival time were not different among groups.
57
A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumours.
Kenneth M. Rassnick,D. B. Bailey,Duncan S. Russell,Andrea B. Flory,M. A. Kiselow,J. L. Intile,E. K. Malone,Cheryl E. Balkman,S. M. Barnard +8 more
TL;DR: Safety and efficacy of a protocol of alternating 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea and vinblastine and prednisone in dogs with mast cell tumours were evaluated and response rate was 65%; five achieved a complete response and six achieved a partial response.
52
In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumors
Kenneth M. Rassnick,Josephia R. Muindi,Candace S. Johnson,Cheryl E. Balkman,Nithya Ramnath,Wei Dong Yu,Kristie L. Engler,Rodney L. Page,Donald L. Trump +8 more
TL;DR: Calcitriol and cisplatin have synergistic antiproliferative effects on multiple canine tumor cells and high-dosages of i.v. calcitriol in combination with cis Platin can be safely administered to dogs, indicating this combination might have significant clinical utility in dogs.
48